ABSTRACT. The unique Physarum lysophosphatidic acid, PHYLPA, having a cyclopropane in the fatty acid moiety and a cyclic phosphate at C-2 and C-3 positions of the glycerol (16), inhibited proliferation of human fibroblast cells, TIG-3 and TIG-7, which were cultured in a chemically defined (serum-free) medium. The cells at S-and M-phases proceeded to G2-and d-phases, respectively, and most of cells were arrested at Gi-or G2-phase during PHYLPA treatment. The growth was recovered when PHYLPA was removed from the medium. In the presence of serum, PHYLPA did not show obvious inhibitory effects, indicating the existence of a factors) which neutralizes the antiproliferative activity of PHYLPA. PHYLPA elicited an increase in 3',5 -cyclic adenosine monophosphate (CAMP) in a biphasic fashion in fibroblast cells. It also elicited inositol phosphate accumulation, as well as a transient rise in cytoplasmic free Ca2+
ABSTRACT. The unique Physarum lysophosphatidic acid, PHYLPA, having a cyclopropane in the fatty acid moiety and a cyclic phosphate at C-2 and C-3 positions of the glycerol (16), inhibited proliferation of human fibroblast cells, TIG-3 and TIG-7, which were cultured in a chemically defined (serum-free) medium. The cells at S-and M-phases proceeded to G2-and d-phases, respectively, and most of cells were arrested at Gi-or G2-phase during PHYLPA treatment. The growth was recovered when PHYLPA was removed from the medium. In the presence of serum, PHYLPA did not show obvious inhibitory effects, indicating the existence of a factors) which neutralizes the antiproliferative activity of PHYLPA. PHYLPA elicited an increase in 3',5 -cyclic adenosine monophosphate (CAMP) in a biphasic fashion in fibroblast cells. It also elicited inositol phosphate accumulation, as well as a transient rise in cytoplasmic free Ca2+
ion.
The roles of membrane phospholipids in the regulation of cell proliferation have long been discussed (2, 9, 14, 17, 18, 26, 29) . Recently, the simplest phospholipid, lysophosphatidic acid (LPA), has been reported to act as a hormone-like lipid mediator which induces mitogenic responses in cultured fibroblasts through a pertussis toxin-sensitive signaling pathway (7, 14, 26) . On the other hand, serum albumin-bound LPA produced during blood clotting has been reported to play an important physiological role in linking platelet activation to receptor-mediated tissue regeneration (24). LPAs are considered to be produced in platelets from PI and PA, and to associate with serum albumin (1, 3, ll), and may represent a major cell growth regulatory component of serum (4). LPAs also induce a variety of cellular effects (22, 23, 24 Fig. 1) , was added to cultures of human fibroblast cells, TIG-3 or TIG-7, grown in the serum-free medium, cell proliferation was apparently inhibited as shown in Fig.   2 . The inhibition was dose-dependent, and a half maximal effect was observed at 4 fjtg/ml (approx. 10 fiM). In contrast, other known LPAs (1-palmitoyl LPA or 1-oleoyl LPA) showed significant mitogenic activity in human fibroblast growth ( Fig. 2) as reported earlier in the case of Rat-1 cells and^^-transformed
Rat-1 cells, NIH 3T3 (7, 26). PAs (1-palmitoyl, 2-oleoyl or 1,2-oleoyl), LPE, DG, and 1,2-phosphatidyl glycerol were all ineffective in inhibiting the cell growth (data not shown). TIG-7 cells showed a slightly higher sensitivity to PHYLPA (cf. ture medium, suggesting the existence of a factor(s) which neutralizes the activity of PHYLPA in the serum. When the concentration of FBS was lowered to 1%, obvious inhibition of the proliferation by PHYLPA was observed (data not shown). Fatty acid-free BSA at concentrations of 0.05-0.5 mg/ml did not interfere with the inhibitory activity of PHYLPA. Growth inhibition by PHYLPA was not due to cell death because the cell viability was virtually identical to that of cultures grown in the absence of PHYLPA. The growth was reversibly recovered when PHYLPA was removed from the medium (Fig. 3) .
No difference in the antiproliferative effect of PHYL-PA was observed when different kinds of growth factors were added (Fig. 4) . Morphological appearance of the TIG-7 cells under these conditions are shown in Fig.  5 . Cells appeared to be healthy and intact whenever their growth were almost inhibited (at 5 /ig/ml). Flow cytometric analysis was done to determine whether PHYLPA had an inhibitory effect on the cell cycle (Fig. 6 ). PHYLPA induced a decrease in the number of S-phase cells, and an increase in that of G2-phase cells. Cells at M-phase proceeded to postmitotic phase, Gi, and no further. A ctivation ofphosphoinositide/Ca2+ signaling pathway byPHYLPA. LPA action was reported to be accompanied by an activation of phosphoinositide hydrolysis/Ca2+/protein kinase C (PKC) pathway in different kinds of cells, platelets (ll), fibroblasts (7, 26, 27), and Xenopus oocytes (22). This suggested that LPA plays an important role in receptor-mediated cell-to-cell signaling. Van der Bend et al. showed the possible existence of a putative membrane receptor for LPA (28) . We then examined the possible correlation of this sig- naling pathway in PHYLPA-induced antiproliferative effect on the fibroblasts.
As shown in Fig. 7(a) , PHY-LPA elicited an increase in cellular IP3 with a peak at 2.5-5.0min
after the addition of PHYLPA. The response to PHYLPA was dose-dependent with a half m aximal effect at about 5 fjtg/ml (approx. 10 fiM).
PHYLPA stimulation of human fibroblasts immediately rose in intracellular free Ca2+ concentration ( in CAMP during the mitogenic activation of cells by LPA has been reported (20, 26, 27) , and the mitogenic action of LPA is considered to be mediated by Gi/G0
protein-coupled branch of the CAMP system. To study whether the CAMP system is involved in the PHYLPAinduced antiproliferation, we studied the changes in the levels of intracellular CAMP concentration after PHY-LPA treatment.
PHYLPA elicited a quick rise in cellular CAMP level in a biphasic manner as shown in Fig. 8 Signaling pathway in PHYLPA action. We examined the mechanisms of signal transduction underlying the antiproliferative activity of PHYLPA in human fibroblast cells. PHYLPA caused an activation of phosphoinositide hydrolysis/Ca2+ mobilization/PKC activation pathway and an increase in CAMP, both of which may be mediated by some G proteins. The involvement of these signaling pathways in PHYLPA effect is suggested, but we have no evidence which of these biochemical responses is critical for the antiproliferative action of PHYLPA or which G protein(s) contributes to this antimitogenic action. Further investigation is necessary to resolve these questions. For more than 10 years, however, CAMP has been recognized as a modulator of cell proliferation (19, 21), and agents which raise an intracellular CAMP level exert a marked growth-inhibiting effect (5, 6). From this recognition, it seems reasonable to assume that an increase in intracellular CAMP may be critical for the antiproliferative action by PHYLPA. Detailed studies on the mechanism of the rise in CAMP and the correlation of G protein(s) are now progressing in our laboratory. 
